PROCEPT BioRobotics Corporation (PRCT) Misses Q4 EPS by 9c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q4 EPS of ($0.63), $0.09 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $23.78 million versus the consensus estimate of $22.91 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• Truist Securities Downgrades Procept BioRobotics Corp (PRCT) to Hold
• SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold